Brief: AlloVir Reports Second Quarter 2022 Financial Results

Kalaris Therapeutics

04/08/2022 12:32

Aug 4 (Reuters) - Allovir Inc  ALVR.O :
    * ALLOVIR REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
    * ALLOVIR INC- FOR FISCAL YEAR 2022, ALLOVIR CONTINUES TO
EXPECT
OPERATING EXPENSES TO BE IN RANGE OF $130 MILLION TO $145
MILLION
    * ALLOVIR INC- AS OF JUNE 30, 2022, ALLOVIR HAD CASH, CASH
EQUIVALENTS AND MARKETABLE SECURITIES OF $172.7 MILLION
    * ALLOVIR INC - QTRLY NET LOSS PER SHARE  BASIC AND DILUTED
$0.69

Source text for Eikon:  ID:nBwb5M2m9a 
Further company coverage:  ALVR.O 

 ((Reuters.Briefs@thomsonreuters.com;))